Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $21.14 +0.57%
EPS Growth %: +17.6%
Financial Fact:
Revenues: 24.65M
Today's EPS Names:
CCEL, FNGR, FAST, More
EPS Growth %: +17.6%
Financial Fact:
Revenues: 24.65M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q2 EPS of ($0.35), $0.07 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $38.5 million versus the consensus estimate of $31.26 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2021 revenue of $148-155 million, versus the consensus of $150.2 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citigroup (C) Tops Q2 EPS by 42c
- Citi opens 90-day upside catalyst watch on Full Truck Alliance
- Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
